Ultragenyx Pharmaceutical | RARE - DEBITO





DEBITO Cambiamento Data
Acadia Pharmaceuticals USD 50.79M 1.39M 2026-03
Agios Pharmaceuticals USD 35.74M 4.46M 2026-03
Alnylam Pharmaceuticals USD 1.27B 5.33M 2026-03
BioCryst Pharmaceuticals USD 828.6M 510K 2024-12
BioMarin Pharmaceutical USD 1.44B 833.74M 2026-03
Immunic USD 0 0 2024-06
Insmed USD 725.8M 1.82M 2026-06
Ionis Pharmaceuticals USD 1.91B 425.5M 2026-06
Karyopharm Therapeutics USD 299.23M 35.14M 2025-12
Kyowa Hakko Kirin JPY 28.75B 5.04B 2024-12
MacroGenics USD 36.51M 500K 2026-03
Moderna USD 1.3B 7M 2026-03
Neurocrine Biosciences USD 406.2M 9.1M 2026-03
PTC Therapeutics USD 286.94M 2.42B 2026-03
Puma Biotechnology USD 89.06M 55.07M 2024-06
Regeneron Pharmaceuticals USD 2.71B 400K 2026-06
Sarepta Therapeutics USD 1.04B 3.08M 2026-03
Ultragenyx Pharmaceutical USD 36M 2.17M 2025-12
Vertex Pharmaceuticals USD 1.98B 8.9M 2026-06